课题基金 / 基金详情

MULTI-SUBSTRATE TYPE INHIBITORS FOR CDC2 KINASE AND THEIR EVALUATION AS SELECTIVE CELL-CYCLE INHIBITORS

MULTI-SUBSTRATE TYPE INHIBITORS FOR CDC2 KINASE AND THEIR EVALUATION AS SELECTIVE CELL-CYCLE INHIBITORS
CDC2 激酶的多底物类型抑制剂及其作为选择性细胞周期抑制剂的评估
批准号:
05671754
负责人:
SASAKI Shigeki
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

SASAKI Shigeki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Protein kinases play a significan role in the signal transduction in cell, and are essential enzymes in maintaining norma cell functions. Protein kinases constitue a diverse family of related enzymes, which have similar structures in their catalytic sites. Therefore, it has been a difficult and challenging task to develop their selective inhibitors. We designed new inhibitors which have multisubstrate type structures (IV-VIII), i.e.bisindolylmaleimide for the ATP-binding site of the enzyme, tetrapeptide for the peptide-binding sites, and a spacer linking these units. In the in vitro inhibition assay using activated complex of cdc2 kinase-cycline B,new compounds (Va and VIb) were found to have potent inhibitory activities (Table).
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Sasaki,Shigeki: "3‐Acetoxy‐2,2′‐Bi‐1H‐indol as A Novel Inhibitor of ATP Binding to DnaA,the Protein Initiating Chromosomal Replication in Escherichiacoli," Bioorg&Med.Chem.Lett.4. 1771-1774 (1994)
Sasaki, Shigeki:“3-Acetoxy-2,2-Bi-1H-indol 作为 ATP 与 DnaA(大肠杆菌中启动染色体复制的蛋白质)结合的新型抑制剂,”Bioorg&Med.Chem.Lett.4。 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasaki, Shigeki: "3-A cetoxy-2,2'-Bi-1H-indol as A Novel Inhibitor of ATP Binding to DnaA,the Protein Initiating Chromosomal Replication in Escherichia coli" Bioorg&Med.Chem.Lett.4. 1771-1774 (1994)
Sasaki, Shigeki:“3-A cetoxy-2,2-Bi-1H-indol 作为 ATP 与 DnaA(大肠杆菌中启动染色体复制的蛋白质)结合的新型抑制剂”Bioorg
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasaki, Shigeki: "Synhtesis of New Fluorine-18 Labeled Benzofuran Benzamide and its in vivo Evaluation as Dopamine D2 Radioligand" J.Labelled.Compd.Radiopharm.34. 435-436 (1994)
Sasaki,Shigeki:“新型氟 18 标记苯并呋喃苯甲酰胺的合成及其作为多巴胺 D2 放射性配体的体内评价”J.Labelled.Compd.Radiopharm.34。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasaki, Shigeki: "Novel Calcium Ionophres : Supramolecular Complexation by The Hydroxylated-Bistetrahydrofuran Skeleton of Potent Antitumor Annonaceous Acetogenins" Tetrahedron Letters. 35. 3337-3340 (1994)
Sasaki,Shigeki:“新型钙离子载体:强效抗肿瘤安非那斯 Acetogenins 的羟基化双四氢呋喃骨架的超分子络合”四面体快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Development of the selective capture molecule for 8-nitroguanosine
    • 批准号:
      24659008
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      SASAKI Shigeki
    • 依托单位:
    Study on the innovative molecular-targeting medicine based on the nano-DDS encapsulating intelligent artificial oligonucleotides
    • 批准号:
      21229002
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $132.54万
    • 财政年份:
      2009
    • 负责人:
      SASAKI Shigeki
    • 依托单位:
    Development of Genome-Targeting Molecules with Ability of Chemical Reactivity and Application to Intelligent Nano-Medicine
    • 批准号:
      17209001
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.78万
    • 财政年份:
      2005
    • 负责人:
      SASAKI Shigeki
    • 依托单位:
    Design of functional molecules for selective recognition and reaction to the duplex DNA
    • 批准号:
      15390007
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.41万
    • 财政年份:
      2003
    • 负责人:
      SASAKI Shigeki
    • 依托单位:
    海外基金